HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
-23.72%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.33B
AUM Growth
+$2.33B
(-16%)
Cap. Flow
+$76.2M
Cap. Flow
% of AUM
3.28%
Top 10 Holdings %
Top 10 Hldgs %
52.39%
Holding
72
New
16
Increased
17
Reduced
10
Closed
23
Top Buys
| 1 |
Encompass Health
EHC
|
$97.7M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$94.2M |
| 3 |
Haemonetics
HAE
|
$89.6M |
| 4 |
CVS Health
CVS
|
$73.2M |
| 5 |
Welltower
WELL
|
$72.4M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$140M |
| 2 |
Johnson & Johnson
JNJ
|
$100M |
| 3 |
Hologic
HOLX
|
$64.5M |
| 4 |
XENT
Intersect ENT, Inc
XENT
|
$63.2M |
| 5 |
Danaher
DHR
|
$50.5M |
Sector Composition
| 1 | Healthcare | 93.12% |
| 2 | Real Estate | 5.44% |
| 3 | Industrials | 0% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVRO
1
DELISTED
NEVRO CORP.
NVRO
| $175M | 7.49% | 1,752,620 +582,540 | +50% | +$58.2M |
|
|
2
Haemonetics
HAE
$2.63B
| $143M | 6.13% | 1,438,356 +899,394 | +167% | +$89.6M |
|
3
Aurinia Pharmaceuticals
AUPH
$1.58B
| $142M | 6.06% | 9,763,920 +4,943,590 | +103% | +$71.7M |
|
4
Labcorp
LH
$23.1B
| $136M | 5.83% | 1,079,726 +226,826 | +27% | +$28.7M |
|
5
Neurocrine Biosciences
NBIX
$13.8B
| $134M | 5.73% | 1,547,740 +740,876 | +92% | +$64.1M |
|
6
Teleflex
TFX
$5.59B
| $119M | 5.09% | 406,930 +97,310 | +31% | +$28.5M |
|
|
7
Encompass Health
EHC
$12.3B
| $97.7M | 4.18% | +1,525,809 | New | +$97.7M |
|
|
8
Acadia Pharmaceuticals
ACAD
$4.38B
| $94.2M | 4.03% | +2,230,474 | New | +$94.2M |
|
9
Madrigal Pharmaceuticals
MDGL
$9.76B
| $93.6M | 4% | 1,402,250 +313,940 | +29% | +$21M |
|
10
Zimmer Biomet
ZBH
$21B
| $83.3M | 3.56% | 824,220 +377,208 | +84% | +$38.1M |
|
|
BPMC
11
DELISTED
Blueprint Medicines
BPMC
| $74.9M | 3.2% | 1,280,370 +971,832 | +315% | +$56.8M |
|
12
Charles River Laboratories
CRL
$8.04B
| $73.8M | 3.15% | 584,620 +409,620 | +234% | +$51.7M |
|
|
13
CVS Health
CVS
$92.8B
| $73.2M | 3.13% | +1,234,120 | New | +$73.2M |
|
|
14
Welltower
WELL
$113B
| $72.4M | 3.1% | +1,582,360 | New | +$72.4M |
|
15
Humana
HUM
$36.5B
| $64M | 2.74% | 203,870 +47,440 | +30% | +$14.9M |
|
16
Bausch Health
BHC
$2.74B
| $59.2M | 2.53% | +3,819,630 | New | +$59.2M |
|
17
LivaNova
LIVN
$3.08B
| $55.5M | 2.37% | +1,225,890 | New | +$55.5M |
|
18
Omega Healthcare
OHI
$12.6B
| $54.1M | 2.31% | +2,038,390 | New | +$54.1M |
|
19
IQVIA
IQV
$32.4B
| $51.6M | 2.21% | 478,580 +194,050 | +68% | +$20.9M |
|
20
UnitedHealth
UNH
$281B
| $42.6M | 1.82% | 170,830 -127,890 | -43% | -$31.9M |
|
21
CONMED
CNMD
$1.68B
| $39.4M | 1.68% | 687,466 +151,446 | +28% | +$8.67M |
|
22
AbbVie
ABBV
$372B
| $35.3M | 1.51% | +463,900 | New | +$35.3M |
|
23
Pediatrix Medical
MD
$1.5B
| $30.8M | 1.32% | 2,646,200 +1,571,720 | +146% | +$18.3M |
|
|
AMRN
24
Amarin Corp
AMRN
$311M
| $30.5M | 1.31% | 7,637,161 +6,076,091 | +389% | +$24.3M |
|
25
Medtronic
MDT
$119B
| $30.1M | 1.28% | 333,330 -514,370 | -61% | -$46.4M |
|